Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Skin reactions from cancer treatments might predict how well the treatments work.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.